Akèy › Tit travay › QC Chemist
QC Chemist: Salè H-1B
95 aplikasyon kondisyon travay te itilize tit travay QC Chemist. Salè baz medyàn ofri $70,000; mwatye mitan $62,500–$81,000.
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Novitium Pharma LLC. | 26 | $62,500 |
| APPCO Pharma LLC | 13 | $65,000 |
| Navinta, LLC | 8 | $89,000 |
| Accuon Labs Inc. | 4 | $69,000 |
| InvaGen Pharmaceuticals, Inc. | 4 | $72,500 |
| KVK-Tech, Inc. | 3 | $85,000 |
| Splint Pharma LLC | 3 | $76,814 |
| Bactolac Pharmaceutical Inc. | 3 | $96,000 |
| Sciegen Pharmaceuticals Inc. | 3 | $88,240 |
| The Veritas Healthcare Solutions LLC | 3 | — |
| JICOR Solutions Inc | 2 | $81,000 |
| Ingenus Pharmaceuticals NJ, LLC | 2 | $69,750 |
| Commissioning Partners LLC | 2 | $104,000 |
| Nature's Value Inc | 1 | $67,000 |
| JLAN USA Technologies | 1 | $81,000 |
| AstaTech, Inc. | 1 | $65,000 |
| KriGen Pharmaceuticals LLC | 1 | $70,000 |
| InvaTech Pharma Solutions LLC | 1 | $60,902 |
| ANIP Acquisition Company | 1 | $65,686 |
| Pioneer Life Science LLC | 1 | $60,902 |
| Veranova, L.P. | 1 | $70,012 |
| Surark Pharma Bottles & Closures LLC | 1 | $62,317 |
| Raritan Pharmaceuticals, Inc. | 1 | $72,800 |
| Navinta III Inc. | 1 | $73,000 |
| Aviva Natural Supplements LLC | 1 | $63,500 |
| QvalFocus Inc. | 1 | $80,990 |
| CMIC CMO USA Corporation | 1 | $90,000 |
| Novozen Healthcare LLC. | 1 | $72,800 |
| United Pharma Technologies, Inc. | 1 | $145,600 |
| AnaSpec, Inc. | 1 | $78,270 |
| Bioactive Services LLC | 1 | $65,000 |
| Havix Group Inc. | 1 | $76,000 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $64,250 |
| Nivo II (kalifye) | $81,000 |
| Nivo III (eksperyans) | $100,000 |
| Nivo IV (plen kompetans) | $129,300 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 15 | $80,184 |
| FY2024 | 18 | $67,843 |
| FY2025 | 40 | $62,500 |
| FY2026 | 18 | $77,135 |
Vil yo
- East Windsor, NJ26
- Piscataway, NJ13
- Hauppauge, NY11
- Ewing, NJ8
- Newtown, PA3
- New York, NY3
- East Brunswick, NJ3
- Pennington, NJ3
- Fairfield, NJ2
- Central Islip, NY2
- South Plainfield, NJ2
- Cranbury, NJ2
- Fall River, MA2
- Coram, NY1
- Ronkonkoma, NY1
- Bristol, PA1
- Lillington, NC1
- Baudette, MN1
- Devens, MA1
- Northborough, MA1
- Chantilly, VA1
- Somerville, NJ1
- Plano, TX1
- Boca Raton, FL1
- New Brunswick, NJ1
- Charles City, IA1
- Fremont, CA1
- Hoschton, GA1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).